Ocular Myasthenia Gravis with Ophthalmoparesis or Ptosis: What to Do When Steroid-Sparing Immunosuppressants Did Not Achieve Complete Resolution

This protocol is for patients with ocular myasthenia gravis (ocular MG) presenting with ophthalmoparesis or ptosis whose prior treatment with steroid-sparing immunosuppressant agents did not achieve complete resolution of ophthalmoparesis — the clinical target required to remain on that line.

Clinical Scenario

Ocular MG with persisting ophthalmoparesis or ptosis that is functionally limiting or troublesome to the patient, despite prior immunosuppressant management. The patient has not reached the required clinical threshold on the preceding treatment line.

Previous Treatment — Insufficient Response

The prior line used steroid-sparing immunosuppressant agents. The required target — complete resolution of ophthalmoparesis — was not reached, triggering escalation to this protocol.

Next-Step Approach

For patients who meet specific eligibility criteria, a surgical intervention is among the options considered at this stage. The full clinical pathway — including eligibility, sequencing, and supporting evidence — is available in the structured protocol.

Treatment Goal

Complete stable remission — asymptomatic without medications.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1212/WNL.0000000000011124

Ophthalmoparesis or ptosis in ocular MG that is not responding to anticholinesterase agents should be treated with immunosuppressant agents if symptoms are functionally limiting or troublesome to the patient.

AChR-Ab+ patients with ocular MG who do not respond adequately to acetylcholinesterases and who either prefer not to take IS therapy or have contraindications to or are refractory to IS agents may be offered thymectomy.

A retrospective case series of 110 patients with ocular MG who underwent extended transsternal thymectomy reported that at a median follow-up of 33.5 months, 26% achieved complete remission (defined as asymptomatic without medications for 12 months).

View source ↗